0001857448-25-000002.txt : 20250613 0001857448-25-000002.hdr.sgml : 20250613 20250613154924 ACCESSION NUMBER: 0001857448-25-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250613 DATE AS OF CHANGE: 20250613 EFFECTIVENESS DATE: 20250613 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Maxona Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001857448 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-548944 FILM NUMBER: 251046232 BUSINESS ADDRESS: STREET 1: 300 VILLAGE DRIVE STREET 2: SUITE 719 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 BUSINESS PHONE: 484.684.7737 MAIL ADDRESS: STREET 1: 300 VILLAGE DRIVE STREET 2: SUITE 719 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 D 1 primary_doc.xml X0708 D LIVE 0001857448 Maxona Pharmaceuticals, Inc. 101 Lindenwood Drive Suite 225 Malvern PA PENNSYLVANIA 19355 484.681.5626 DELAWARE None None Corporation true Shahin Fatholahi 101 Lindenwood Drive Suite 225 Malvern PA PENNSYLVANIA 19355 Executive Officer Director Behshad Sheldon 101 Lindenwood Drive Suite 225 Malvern PA PENNSYLVANIA 19355 Director David Nakamura 101 Lindenwood Drive Suite 225 Malvern PA PENNSYLVANIA 19355 Director Richard Brand 101 Lindenwood Drive Suite 225 Malvern PA PENNSYLVANIA 19355 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2025-06-04 false true false 0 Arcadia Securities, LLC 44656 None None 1370 Avenue of the Americas, 29th Floor New York NY NEW YORK 10019 AZ ARIZONA CA CALIFORNIA CO COLORADO CT CONNECTICUT FL FLORIDA NV NEVADA NY NEW YORK PA PENNSYLVANIA RI RHODE ISLAND TN TENNESSEE TX TEXAS WI WISCONSIN false 5000000 900163 4099837 false 15 68865 0 550000 true false Maxona Pharmaceuticals, Inc. Shahin Fatholahi Shahin Fatholahi Chief Executive Officer 2025-06-13